Report overview
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.
This report aims to provide a comprehensive presentation of the global market for Over the Counter (OTC) Drugs & Dietary Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over the Counter (OTC) Drugs & Dietary Supplements. This report contains market size and forecasts of Over the Counter (OTC) Drugs & Dietary Supplements in global, including the following market information:
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Analgesic & Pain Relievers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Over the Counter (OTC) Drugs & Dietary Supplements include Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc. and Bayer Healthcare AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Over the Counter (OTC) Drugs & Dietary Supplements companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Over the Counter (OTC) Drugs & Dietary Supplements Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Segment Percentages, by Type, 2022 (%)
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Global Over the Counter (OTC) Drugs & Dietary Supplements Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
Global Over the Counter (OTC) Drugs & Dietary Supplements Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Over the Counter (OTC) Drugs & Dietary Supplements revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Over the Counter (OTC) Drugs & Dietary Supplements revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Over the Counter (OTC) Drugs & Dietary Supplements, market overview.
Chapter 2: Global Over the Counter (OTC) Drugs & Dietary Supplements market size in revenue.
Chapter 3: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Over the Counter (OTC) Drugs & Dietary Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
